Gil Omenn

Gil Omenn

Director/Board Member presso GALECTIN THERAPEUTICS INC.

Patrimonio netto: 265 718 $ in data 29/02/2024

83 anni
Commercial Services
Health Technology
Consumer Services

Profilo

Gil S.
Omenn
is Member-Community Preventive Services Task Force at Centers for Disease Control & Prevention, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Association of American Physicians and Vice President of Human Proteome Organization and on the board of 10 other companies.
Gil S.
Omenn
previously occupied the position of Chief Executive Officer of University of Miami Health System, Associate Director at Office of Management & Budget, Associate Director at White House Office of Science & Technology Policy, Advisor at Arboretum Ventures LLC, Chairman for tranSMART Foundation, Member-Scientific Management Review at National Institutes of Health, Associate Director at Office of Science & Technology Policy, Member of American College of Physicians, Inc., Chief Executive Officer of Michigan Medicine, President of American Association for the Advancement of Science, Executive VP-Medical Affairs & Professor at the University of Michigan, Professor at the University of Washington, Affiliate Faculty at Institute for Systems Biology, Council Member at National Academy of Medicine (United States) and Member of Fred Hutchinson Cancer Research Center.
Gil S.
Omenn
received a doctorate from the University of Washington, a doctorate from Harvard Medical School and an undergraduate degree from Princeton University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
24/01/2024 82 240 ( 0.13% ) 160 779 $ 29/02/2024
01/09/2023 50 000 ( 3.57% ) 97 750 $ 29/02/2024
08/12/2023 3 472 ( 0.14% ) 7 187 $ 29/02/2024
Amesite, Inc. /Old/
0.96%
16/01/2024 155 790 ( 0.96% ) 2 $ 30/11/2021

Posizioni attive di Gil Omenn

SocietàPosizioneInizio
GALECTIN THERAPEUTICS INC. Director/Board Member 23/09/2014
AMESITE INC. Director/Board Member 01/03/2020
Director/Board Member -
Corporate Officer/Principal -
Director/Board Member 20/05/2011
Director/Board Member -
Human Proteome Organization Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tutte le posizioni attive di Gil Omenn

Precedenti posizioni note di Gil Omenn

SocietàPosizioneFine
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Gil Omenn

Formazione di Gil Omenn

University of Washington Doctorate Degree
Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gil Omenn

Relazioni

100 +

Relazioni di 1° grado

42

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
AMGEN INC.

Health Technology

ESPERION THERAPEUTICS, INC.

Health Technology

GALECTIN THERAPEUTICS INC.

Health Technology

Aziende private34

Process Industries

Health Technology

Health Services

Health Technology

Government

Government

Commercial Services

Commercial Services

Office of Science & Technology Policy

Government

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Human Proteome Organization

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Miscellaneous

The Hastings Center

Life Sciences Society

Health Services

Health Technology

Commercial Services

Amesite, Inc. /Old/

Technology Services

Amesite, Inc.

Office of Management & Budget

MedsynBio LLCuu

White House Office of Science & Technology Policy

Finance

Commercial Services

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Gil Omenn